Meeting
2023 ASCO Annual Meeting
Cancer of unknown primary with gastrointestinal profiles: A distinct CUP subset.
Authors
Aakash Tushar Shah
Baylor College of Medicine, Houston, TX
Aakash Tushar Shah , Jeannelyn Estrella , Priyadarsini Dasari , Anneleis Willett , Joelle Allam , Victoria Higbie , Phat Le , Michael Sangmin Lee , Aurelio Matamoros Jr., Elizabeth A Lano , Kanwal Pratap Singh Raghav , Ryan W Huey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3606)
DOI
10.1200/JCO.2023.41.16_suppl.3606
Abstract #
3606
Poster Bd #
306
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Immunohistochemical and genetic profiles do not predict behavior of mixed hepatocellular intrahepatic cholangiocarcinoma.
First Author: Santiago Sucre
Poster
2017 ASCO Annual Meeting
Upfront short course radiotherapy (SCRT) in metastatic rectal cancer (mRC): A way forward.
First Author: Shanu Jain
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Phase II study of the safety and efficacy of discontinuing pegfilgrastim for pancreatic adenocarcinoma treated with FOLFIRINOX.
First Author: Masahiro Yanagi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.
First Author: Kaushal Desai